Unilife markets ready-to-fill and prefilled syringes, which with...

Unilife markets ready-to-fill and prefilled syringes, which with built-in safety features, have attracted the attention of pharmaceutical companies such as sanofi-aventis. Sanofi paid Unilife a $12.5 million exclusivity fee for two years to make ready-to-fill syringes for a list of exclusive therapeutic drugs, and more recently entered into an arrangement with one of the country's largest medical supply cooperatives to supply 1 milliliter syringes to U.S. health-care facilities.

With the co-op focusing on the physician and long-term care market, it's giving Unilife a large portal to enter markets that consume a significant proportion of all 1mL safety syringes manufactured each year.

The one Wall Street analyst following Unilife is looking for better than average returns, as are all the CAPS All-Star members who've rated it. In fact, only two members think it will nick itself going forward, but only you can decide whether this medical device company deserves a spot in your portfolio. Add Unilife to the Fool's free portfolio tracker to keep on top of all the news and analysis about this security leader.

http://www.fool.com/investing/general/2010/12/15/hidden-stocks-for-high-returns.aspx